FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely biochemistry and physiology, and can be used for modeling normobaric chronic hypoxia. For this purpose, for 14 days laboratory animals are placed in medium of oxygen decrease under conditions of normal atmospheric pressure with termination of session with reduction of oxygen concentration to 10% in inhaled air.
EFFECT: method enables optimizing the modeling of normobaric chronic hypoxia without lifting to height in the absence of mortality of animals during the experiment by individual determination of the length of stay in the hermetic chamber of each animal by gas analyzer.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR MODELING ACUTE EXOGENOUS NORMOBARIC HYPOXIA WITHOUT HYPERCAPNIA IN SMALL LABORATORY ANIMALS | 2005 |
|
RU2291498C1 |
| METHOD FOR INCREASING BODY RESISTANCE TO ACUTE HYPOXIA IN EXPERIMENT | 2013 |
|
RU2517032C1 |
| METHOD OF CANCER TREATMENT AND RELATED DEVICE | 2006 |
|
RU2326701C2 |
| METHOD OF SIMULATING SECONDARY POSTHYPOXIC IMMUNODEFICIENCY OF DISREGULATORY TYPE WITH TRANSIENT FAILURE OF CD4-POSITIVE LYMPHOCYTES | 2015 |
|
RU2609281C1 |
| METHOD OF TREATING WITH USING EXTREME HYPOXIA AND HYPERCAPNIA | 2008 |
|
RU2387463C1 |
| PHARMACEUTICAL COMPOSITION, POSSESSING ANTIHYPOXIC, NEUROPROTECTIVE AND ANTIAMNESTIC ACTIVITY, INCREASING PHYSICAL WORKABILITY | 2013 |
|
RU2564008C2 |
| CONTROLLABLE BREATHING EXERCISER | 2006 |
|
RU2320375C2 |
| METHOD FOR TREATMENT OF ERTERNAL HYPERCAPNIC HYPOXIA | 2015 |
|
RU2655262C2 |
| AGENT WITH ANTIHYPOXIC ACTIVITY | 2022 |
|
RU2797210C1 |
| AGENT POSSESSING NEUROPROTECTIVE, ANTIAMNESTIC, ANTIHYPOXIC, ANTIOXIDANT AND ANTIISCHEMIC ACTIVITY, AND METHOD FOR PREVENTING AND TREATING ACUTE AND CHRONIC DISTURBED CEREBRAL CIRCULATION | 2011 |
|
RU2465002C1 |
